BR0010298A - Fator de regulação celular tto 20 - Google Patents

Fator de regulação celular tto 20

Info

Publication number
BR0010298A
BR0010298A BR0010298-9A BR0010298A BR0010298A BR 0010298 A BR0010298 A BR 0010298A BR 0010298 A BR0010298 A BR 0010298A BR 0010298 A BR0010298 A BR 0010298A
Authority
BR
Brazil
Prior art keywords
tto
regulation factor
cellular regulation
dna encoding
factor tto
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
BR0010298-9A
Other languages
English (en)
Inventor
Klaus-Peter Koller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
sanofi-aventis Deutschland GmbH
Original Assignee
sanofi-aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by sanofi-aventis Deutschland GmbH filed Critical sanofi-aventis Deutschland GmbH
Publication of BR0010298A publication Critical patent/BR0010298A/pt
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Patente de Invenção: "FATOR DE REGULAçãO CELULAR TTO 20". A invenção refere-se ao fator de regulação celular TTO 20, ao DNA codificador dele, sua preparação e emprego, anticorpos ligados a TTO 20 assim como ao emprego do DNA codificador de TTO 20 e um anticorpo ligado a TTO 20 para emprego em um kit de diagnóstico para verificação de doenças inflamatórias, particularmente artrite reumatóide.
BR0010298-9A 1999-05-03 2000-04-14 Fator de regulação celular tto 20 Withdrawn BR0010298A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19920004A DE19920004C1 (de) 1999-05-03 1999-05-03 Neuer zellulärer Regulationsfaktor TTO 20
PCT/EP2000/003381 WO2000066726A1 (de) 1999-05-03 2000-04-14 Neuer zellulärer regulationsfaktor tto 20

Publications (1)

Publication Number Publication Date
BR0010298A true BR0010298A (pt) 2002-02-13

Family

ID=7906608

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010298-9A Withdrawn BR0010298A (pt) 1999-05-03 2000-04-14 Fator de regulação celular tto 20

Country Status (14)

Country Link
US (2) US6468750B1 (pt)
EP (1) EP1177294A1 (pt)
JP (1) JP2002542822A (pt)
KR (1) KR20020034078A (pt)
AU (1) AU767539B2 (pt)
BR (1) BR0010298A (pt)
CA (1) CA2373018A1 (pt)
DE (1) DE19920004C1 (pt)
IL (1) IL146199A0 (pt)
MX (1) MXPA01010884A (pt)
NO (1) NO20015310L (pt)
NZ (1) NZ515219A (pt)
WO (1) WO2000066726A1 (pt)
ZA (1) ZA200109070B (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643758A (en) * 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
US6200802B1 (en) * 1993-10-08 2001-03-13 Arch Development Corporation Human peroxisome proliferator activated receptor gamma: compositions and methods
EP0705842A2 (en) * 1994-10-06 1996-04-10 Hoechst Aktiengesellschaft Regulated genes by stimulation of chondrocytes with 1L-1beta

Also Published As

Publication number Publication date
ZA200109070B (en) 2002-10-30
US6468750B1 (en) 2002-10-22
US20030082634A1 (en) 2003-05-01
NZ515219A (en) 2004-02-27
AU767539B2 (en) 2003-11-13
MXPA01010884A (es) 2002-05-06
NO20015310D0 (no) 2001-10-30
AU4747700A (en) 2000-11-17
EP1177294A1 (de) 2002-02-06
NO20015310L (no) 2001-12-20
DE19920004C1 (de) 2000-10-05
WO2000066726A1 (de) 2000-11-09
JP2002542822A (ja) 2002-12-17
IL146199A0 (en) 2002-07-25
CA2373018A1 (en) 2000-11-09
KR20020034078A (ko) 2002-05-08

Similar Documents

Publication Publication Date Title
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
AU2002351239A8 (en) Antibody to latent membrane proteins and uses thereof
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
BRPI9912227B8 (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
WO2001049728A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
BR9710968A (pt) Antìgenos de célula b humana; reagentes correlatos
EP1067182A8 (en) Secretory protein or membrane protein
ES2085983T3 (es) Antagonistas de anticuerpos de la interleuquina-4 humana.
DE69828045D1 (de) Verbindungen, ihre herstellung und ihre verwendung für den transfer von nucleinsäuren in zellen
DE60033062D1 (de) Antikörper spezifisch für dendritische zellen, zusammensetzungen und verfahren, die diese antikörper verwenden, das durch die antikörper detektierte antigen und die dadurch erhaltenen zellen
DE50015156D1 (de) Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung
BR0207933A (pt) Mutantes de interleucina-18, sua produção e uso
FR2806739B1 (fr) Genes impliques dans les maladies inflammatoires de l'intestin et leur utilisation
WO2001012660A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
TR200102877T2 (tr) İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar.
CA2366514A1 (en) Diagnostic and therapeutic use of antibodies against the urokinase receptor
DE69938725D1 (de) Monoklonale antikörper gegen das protein g3bp und deren verwendungen
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
ATE248189T1 (de) Antikörper gegen vasp (vasodilator-stimulated phosphoprotein), hybridomzellen für deren gewinnung, und deren verwendung
WO2001002563A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
ATE198512T1 (de) Transfizierte zelllinien die autoantigene exprimieren und ihre verwendung in immunotests zur erkennung von autoimmunkrankheiten
BR0010298A (pt) Fator de regulação celular tto 20
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
ATE420365T1 (de) Präparierung von sphären für diagnostische tests
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.